Sort by
Refine Your Search
-
line price index targets, percentage of expenditures on purchase orders, inventory levels, and other related metrics. Generates monthly reports and dashboards and participates in executive reviews
-
onboarding of new-hires surgical techs. Reviews all operational information related to efficiency and productivity matrices and established targets. (First Case On Time Starts (FCOTS) and Turn Around Time (TAT
-
. These services include the use of CRISPR/Cas9 targeting to produce gene knockouts, conditional knockouts, single-point mutations, and insertions and gene fusions, also simultaneously mutating multiple genes in a
-
nationally ranked neurology and neurosurgery programs. UHealth/SoLé Mia has an exciting opportunity for a full-time Sr. Administrative Assistant with a target hire in 6/30/2025. Be part of the UHealth
-
well as top-notch care from UHealth’s nationally ranked neurology and neurosurgery programs. UHealth/SoLé Mia has an exciting opportunity for a full-time Registered Nurse 2 with a target hire in June 30, 2025
-
focusing on ensuring the delivery of consistent messages to the target audience. The Asst. Director, Communications - School/College/Hospital (H) works closely with the leadership team to develop
-
onboarding of new-hires surgical techs. Reviews all operational information related to efficiency and productivity matrices and established targets. (First Case On Time Starts (FCOTS) and Turn Around Time (TAT
-
the design process, ensuring they align with project objectives and standards. Facilitates the design review process, ensuring stakeholder engagement and timely approvals. Implements Target Value Design (TVD
-
Institute as well as top-notch care from UHealth’s nationally ranked neurology and neurosurgery programs. UHealth/SoLé Mia has an exciting opportunity for a full-time Medical Assistant 1 with a target hire in
-
mice and rats by zygote electroporation and pronuclear or cytoplasmic injection of DNA and CRISPR gRNA/cas9; and gene targeting by electroporation and injection of ES/iPS cells into blastocysts